These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19220915)

  • 1. Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography.
    Kutner RH; Puthli S; Marino MP; Reiser J
    BMC Biotechnol; 2009 Feb; 9():10. PubMed ID: 19220915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors.
    Kutner RH; Zhang XY; Reiser J
    Nat Protoc; 2009; 4(4):495-505. PubMed ID: 19300443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Scalable Lentiviral Vector Production and Purification Method Using Mustang Q Chromatography and Tangential Flow Filtration.
    Tinch S; Szczur K; Swaney W; Reeves L; Witting SR
    Methods Mol Biol; 2019; 1937():135-153. PubMed ID: 30706394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection.
    Kuroda H; Kutner RH; Bazan NG; Reiser J
    J Virol Methods; 2009 May; 157(2):113-21. PubMed ID: 19114057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins.
    Marino MP; Panigaj M; Ou W; Manirarora J; Wei CH; Reiser J
    Gene Ther; 2015 Mar; 22(3):280-5. PubMed ID: 25608718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration.
    Cooper AR; Patel S; Senadheera S; Plath K; Kohn DB; Hollis RP
    J Virol Methods; 2011 Oct; 177(1):1-9. PubMed ID: 21784103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
    Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
    Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic Setting.
    Dasgupta A; Tinch S; Szczur K; Ernst R; Shryock N; Kaylor C; Lewis K; Day E; Truong T; Swaney W
    Methods Mol Biol; 2020; 2086():27-60. PubMed ID: 31707666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture.
    Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M
    J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upscaling of lentiviral vector production by tangential flow filtration.
    Geraerts M; Michiels M; Baekelandt V; Debyser Z; Gijsbers R
    J Gene Med; 2005 Oct; 7(10):1299-310. PubMed ID: 15906396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and comparative performance of lentiviral vector preparations concentrated by either one-step ultrafiltration or ultracentrifugation.
    Papanikolaou E; Kontostathi G; Drakopoulou E; Georgomanoli M; Stamateris E; Vougas K; Vlahou A; Maloy A; Ware M; Anagnou NP
    Virus Res; 2013 Jul; 175(1):1-11. PubMed ID: 23583684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and concentration of pseudotyped HIV-1-based gene transfer vectors.
    Reiser J
    Gene Ther; 2000 Jun; 7(11):910-3. PubMed ID: 10849549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of HIV-1-based lentiviral vector particles.
    Ramezani A; Hawley RG
    Curr Protoc Mol Biol; 2002 Nov; Chapter 16():Unit 16.22. PubMed ID: 18265303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corning HYPERFlask
    Kearney BJ; Voorhees MA; Williams PL; Olschner SP; Rossi CA; Schoepp RJ
    J Virol Methods; 2017 Apr; 242():9-13. PubMed ID: 28012899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Large-Scale Downstream Processing for Lentiviral Vectors.
    Valkama AJ; Oruetxebarria I; Lipponen EM; Leinonen HM; Käyhty P; Hynynen H; Turkki V; Malinen J; Miinalainen T; Heikura T; Parker NR; Ylä-Herttuala S; Lesch HP
    Mol Ther Methods Clin Dev; 2020 Jun; 17():717-730. PubMed ID: 32346549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vector production, titration, and transduction of primary neurons.
    Ding B; Kilpatrick DL
    Methods Mol Biol; 2013; 1018():119-31. PubMed ID: 23681623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized production and concentration of lentiviral vectors containing large inserts.
    al Yacoub N; Romanowska M; Haritonova N; Foerster J
    J Gene Med; 2007 Jul; 9(7):579-84. PubMed ID: 17533614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Grade Purification of Third-Generation HIV-Based Lentiviral Vectors by Anion Exchange Chromatography for Experimental Gene and Stem Cell Therapy Applications.
    Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
    Methods Mol Biol; 2019; 1879():347-365. PubMed ID: 30006865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
    Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
    J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.